154.54
price down icon3.16%   -5.04
after-market Handel nachbörslich: 145.55 -8.99 -5.82%
loading

Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten

pulisher
Aug 20, 2025

Stock Analysis | Charles River Laboratories International OutlookA Weak Technical Profile But Strong Fundamentals - AInvest

Aug 20, 2025
pulisher
Aug 20, 2025

Pharmaceutical company to expand Charleston County operations - Live 5 News

Aug 20, 2025
pulisher
Aug 20, 2025

Healthcare firms see growing activist investor involvement in the past year - Reuters

Aug 20, 2025
pulisher
Aug 19, 2025

Charles River Labs scales back Memphis project, slashes expected jobs - The Business Journals

Aug 19, 2025
pulisher
Aug 19, 2025

Clinical Trial Biorepository and Archiving Solutions Market Size Expected to Attain USD 9.69 Billion by 2034 - GlobeNewswire Inc.

Aug 19, 2025
pulisher
Aug 18, 2025

Earnings call transcript: Charles River Labs Q2 2025 beats EPS forecasts - Investing.com Canada

Aug 18, 2025
pulisher
Aug 18, 2025

FRAUD AND MANIPULATION—1st Cir.: CEO’s reaction to macaque conspiracy was actionably misleading - VitalLaw.com

Aug 18, 2025
pulisher
Aug 18, 2025

Huge proposed Memphis project downsizes by 500 jobs - The Business Journals

Aug 18, 2025
pulisher
Aug 17, 2025

Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN

Aug 17, 2025
pulisher
Aug 17, 2025

Are Margin Pressures Shaping Charles River’s (CRL) Competitive Position Amid Stabilizing Revenue Guidance? - simplywall.st

Aug 17, 2025
pulisher
Aug 16, 2025

Is Charles River Laboratories International Inc. exposed to currency risksPortfolio Gains Summary & Real-Time Volume Trigger Notifications - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 16, 2025

How Charles River Laboratories International Inc. stock reacts to Fed policy changesQuarterly Growth Report & Verified Swing Trading Watchlists - beatles.ru

Aug 16, 2025
pulisher
Aug 16, 2025

Day 5 of Gains Streak for Charles River Laboratories International Stock with 5.3% Return (vs. -15% YTD) [8/15/2025] - Trefis

Aug 16, 2025
pulisher
Aug 15, 2025

Charles River Laboratories International Inc. Stock Recovery Path — Analyst Breakdown2025 Market Sentiment & AI Enhanced Execution Alerts - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Profitable Stocks to Watch: Dole, Charles River Laboratories, and LegalZoom - AInvest

Aug 15, 2025
pulisher
Aug 14, 2025

Charles River Laboratories International Inc. Recovery Linked to Earnings Surprise2025 Analyst Calls & Real-Time Market Sentiment Alerts - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Why Charles River Laboratories International Inc. stock attracts strong analyst attentionJuly 2025 Technicals & Weekly High Conviction Trade Ideas - sisa-n.com

Aug 14, 2025
pulisher
Aug 14, 2025

What is Charles River Laboratories International Inc. s 5 year growth outlookJuly 2025 Final Week & Accurate Intraday Trading Signals - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Custom Dashboard Highlights Charles River Laboratories International Inc. Price MomentumEarnings Recap Summary & Technical Entry and Exit Tips - 선데이타임즈

Aug 14, 2025
pulisher
Aug 13, 2025

5 Revealing Analyst Questions From Charles River Laboratories’s Q2 Earnings Call - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

Do Charles River (CRL) Earnings Trends Reveal Shifting Priorities in Its Advanced Therapeutics Ambitions? - simplywall.st

Aug 13, 2025
pulisher
Aug 12, 2025

Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Yahoo Finance

Aug 12, 2025
pulisher
Aug 11, 2025

CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

Interpreting Charles River (CRL) International Revenue Trends - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Charles River Labs: Buy Rating and $179 Price Target Amidst Stability and Value Creation Potential - AInvest

Aug 11, 2025
pulisher
Aug 08, 2025

Charles River Laboratories Q2 2025 Earnings Call Transcript Summary - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Charles River Laboratories International Inc's Q2 2025 Financials and Strategic Direction: A SWOT Analysis - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Charles River Laboratories Reports Q2 2025 Earnings - The Globe and Mail

Aug 08, 2025
pulisher
Aug 07, 2025

Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MSN

Aug 07, 2025
pulisher
Aug 07, 2025

Charles River Laboratories International 2025 Q2 Earnings Misses Targets as Net Income Drops 44% - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 07, 2025
pulisher
Aug 07, 2025

Charles River Laboratories International Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Charles River Laboratories Q2 2025 Earnings Preview - MSN

Aug 07, 2025
pulisher
Aug 06, 2025

Charles River Laboratories International Q2 2025 Earnings Call Transcript - MarketBeat

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River Laboratories International 2025 Q2 Earnings Beats Expectations as Net Income Drops 44.1% - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River: Q2 Earnings Snapshot - Milford Mirror

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River Labs Reports Mixed Q2 Earnings Call - TipRanks

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River Laboratories Shares Drop 10.25% Despite 49.73% Volume Surge Ranking 339th in Market Activity as Order Cancellations Weigh on Investor Sentiment - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River (CRL) Q2 EPS Jumps 11% - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River Labs stock price target raised to $175 by BofA Securities - Investing.com India

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River Laboratories Q2 2025 Earnings Call Transcript Review - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing - Benzinga

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River: Margin Fears Outweigh Solid Q2 (NYSE:CRL) - Seeking Alpha

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River Labs cleared in DOJ monkey investigation, provides strategic review update - The Business Journals

Aug 06, 2025
pulisher
Aug 06, 2025

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $185 From $180 - MarketScreener

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates - sharewise.com

Aug 06, 2025
pulisher
Aug 06, 2025

Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Aug 06, 2025
diagnostics_research WAT
$290.44
price down icon 2.12%
diagnostics_research DGX
$183.72
price down icon 0.37%
$161.95
price up icon 0.82%
diagnostics_research LH
$276.56
price down icon 0.55%
diagnostics_research MTD
$1,278.00
price down icon 2.95%
diagnostics_research IQV
$185.39
price down icon 3.46%
Kapitalisierung:     |  Volumen (24h):